Clinical Trial Update: Phase Ib Trial of MSP3 LSP in Children in Tanzania [Phase 1]

View source ↗

Summary

This document provides an update on a Phase Ib trial of MSP3 LSP for malaria in children in Tanzania.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• MSP3 LSP (MSP3 long synthetic peptide)

Snippet

Sponsor: African Malaria Network Trust | Conditions: Malaria | Phase 1 | Status: UNKNOWN